Cite

HARVARD Citation

    Vascotto, F. et al. (2019). Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell response. Oncoimmunology. p. . [Online]. 
  
Back to record